Abstract:Abstract There is a growing trend towards paperless clinical practice. Apps and web-based tools can help to quickly capture useful clinical information to influence management. We reviewed free digital dermatology tools that are available for clinicians with the goal of promoting awareness of these resources. We conducted a PubMed literature search and searched the Apple App Store using key search terms. We found that web-based platforms or apps available with a dermatological theme that can aid clinical practice can be summarized and categorized into the following four groups. (i) Disease-specific severity assessment in alopecia areata (AASI), atopic eczema (eSCORAD, eEASI, POEM, vIGA_AD), melasma (MASI), psoriasis (ePASI), nail psoriasis (NAPPA-QOL), acne (ePGA), hidradenitis suppurativa (HS-PGA, IHS4, eSartorius, eHurley), chronic urticaria (UAS7, UCT), pressure ulcers (Braden scale), toxic epidermal necrolysis (eSCORTEN), symptom severity assessment in pruritus (PNRS, pruritus VAS), pain (ePain VAS, Neuropathic Pain Scale), obesity (body mass index calculator), leg ulcer (eWoundQoL score) and assessment of quality of life in any skin disorder (eDLQI). Also, staging of skin cancers like melanoma (eTNM) and squamous cell carcinoma (AJCC8, BWH), and estimating survival and risk prediction in melanoma [positive sentinel lymph node biopsy, recurrence, first primary, second primary, immunotherapy outcome prediction (MIA, SweMR)]. (ii) As an aid to diagnosis in Behçet disease, DRESS (RegiSCAR), psoriatic arthritis (DAPSA, CASPAR), scleroderma (RODNAN), systemic lupus erythematosus (EULAR-ACR, SLICC criteria, SLEDAI), necrotizing fasciitis (LRINEC score) and cellulitis (ALT-70); and for depression screening (ePHQ9), suicidality screening (ED-SAFE PSS-3), anxiety screening (GAD-7), excess alcohol consumption (AUDIT-C, CAGE), HIV risk screening (Denver HIV score), predicting life expectancy (Charlson Comorbidity Index), Clinical Frailty Score, mental state (AMT-10) and noninvasive estimate of liver cirrhosis (FIB-4 Index, NAFLD fibrosis score). (iii) To help inform decisions related to skin surgery: decision to stop or continue an anticoagulant before skin surgery (HASBLED), stroke risk in atrial fibrillation (CHA2DS2-VASs score), and a local anaesthetic dosing guide. (iv) For assistance in prescribing: electronic British National Formulary, systemic steroid conversion, hydroxychloroquine maximum daily dose, and Geneva score – inpatient venous thromboembolism prophylaxis. We found the following resources especially useful – MDApp, Dermascore, Dermatools, Dermavalue, MDCalc and the Melanoma Institute of Australia risk prediction tools; these require manual input or selection of relevant data from dropdown lists, enabling the program to calculate the final score. In our experience, use of digital resources facilitates processing of relevant clinical information quickly and efficiently, helping in patient engagement and thorough assessment. We propose that the British Association of Dermatologists could develop a ‘one-stop’ app with multiple scoring tools for dermatologists to use in clinical practice.

P031 Experience from a UK dermatology regional virtual biologics and high-cost drugs multidisciplinary team

Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetings

P17 A Multisite Service Evaluation of Paediatric Teleconsultations

P087 The British Hair and Nail Society present a review of our national grand round of challenging hair disorders and the benefits to the wider British Association of Dermatologists membership

BT19 The rising dermatology advice and guidance pandemic: building a workforce group with nationally implantable solutions that led to significant improvements over a 10-week period

Mixed-methods evaluation of an enhanced asthma biologics clinical pathway in the West Midlands UK

BI17 Impact of an annual multidisciplinary clinic on patient care and experience in cutaneous T-cell lymphoma

BT16 BT17 Dermatology advice and guidance: a service evaluation

Current prescribing for pyoderma gangrenosum in the UK and access to biologic medications: Results from a UK Dermatology Clinical Trials Network (UKDCTN) survey of UK Dermatologists

1058 ESTABLISHING A VIRTUAL MULTIDISCIPLINARY TEAM MEETING FOR CARE HOME RESIDENTS IN NEWCASTLE-UPON-TYNE

Equity, expense, and expertise in biologic commissioning: adding the patient to the equation

P112 The British Hair and Nail Society present a review of our national grand round of challenging nail conditions and the benefits to the wider British Association of Dermatologists membership

BT35 Quality improvement project: modernizing the inpatient dermatology handover

BI15 (P048) Immunosuppression and vaccination: a cross-specialty survey on current practices

BT12 Great expectations: implementing artificial intelligence software into a regional skin cancer teledermatology service

BT26 Apps and web-based tools to use in dermatology practice

Optimizing severe asthma care by consulting an asthma expertise team for biologics

Not all MDTs are created equal: international survey of HPB MDT practices

Acceptability of ‘as needed’ biologic therapy in psoriasis: insights from a multi-stakeholder mixed methods study

Patient and parent perspectives on paediatric cancer multidisciplinary team working and national advisory panels in the UK: a qualitative research study

British Hair and Nail SocietyOral presentationsBH01 (P087) The British Hair and Nail Society present a review of our national grand round of challenging hair disorders and the benefits to the wider British Association of Dermatologists membership